ICM
BAX icon

Invenomic Capital Management’s Baxter International BAX Stock Holding History

Invenomic Capital Management’s Portfolio BAX Stock Details BAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-746,651
Closed -$14.3M – 155
2025
Q4 		$14.3M Buy
746,651
+379,996
+104% +$7.6M 0.66% 54
2025
Q3 		$8.35M Buy
+366,655
New +$9.3M 0.4% 80
2024
Q1 		– Sell
-128,001
Closed -$4.95M – 151
2023
Q4 		$4.95M Sell
128,001
-406,535
-76% -$14.4M 0.23% 110
2023
Q3 		$20.2M Buy
534,536
+13,589
+3% +$579K 0.85% 34
2023
Q2 		$23.7M Sell
520,947
-41,193
-7% -$1.79M 1.2% 26
2023
Q1 		$22.8M Buy
+562,140
New +$23.8M 1.29% 28

Other funds holding BAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GA
Greenhaven Associates Purchase, New York $6.07B AUM 11.2% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Invenomic Capital Management's BAX Position: Q1 2026 in Review

Invenomic Capital Management sold out of Baxter International (BAX) in Q1 2026, closing a stake of 746,651 shares — an estimated $14.3M sold.

Invenomic Capital Management first reported a position in BAX in Q1 2023 and held it in 6 quarters. The position peaked at $23.7M in Q2 2023. 658 funds tracked by Wall St. Rank hold BAX as of Q1 2026.

  • Invenomic Capital Management reported no remaining Baxter International position as of Q1 2026 after selling out during the quarter.
  • Invenomic Capital Management sold 746,651 Baxter International shares in Q1 2026, an estimated $14.3M.
  • Invenomic Capital Management first reported a position in Baxter International in Q1 2023 and held it in 6 quarters.
  • Invenomic Capital Management's Baxter International position peaked at $23.7M in Q2 2023.
  • 658 funds tracked by Wall St. Rank held Baxter International as of Q1 2026.

Based on Invenomic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.